fbpx

#Sandoz

Sandoz announces FDA approval for new biosimilar

New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit and pre-filled syringe for intravitreal injection. Enzeevu is indicated to…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.